Erik Harris, EVP & Chief Commercial Officer at Ultragenyx Pharmaceutical Inc. (RARE), sold 9,536 shares at $53.76 ($513K) on 2024-03-01, disclosed to the SEC on 2024-03-05.
Seasonal sale ($513k) by EVP & Chief Commercial Officer — this insider has traded RARE in March in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $53.76 | 4,768 | $256K | 50.0% |
| 2 | $53.76 | 4,768 | $256K | 50.0% |
| Total | $53.76 avg | 9,536 | $513K | 100% |
| Filing → |
| RARE | SELL | 2023-09-06 | $228K | — | Filing → |
| RARE | SELL | 2023-06-21 | $15K | — | Filing → |
| RARE | SELL | 2023-03-03 | $166K | — | Filing → |